(IN BRIEF) The European Investment Bank and Angelini Ventures have signed a €150 million funding agreement to support early- and growth-stage European startups in biotechnology, medical technology, and digital health. Each partner will invest €75 million over six years in … Read the full press release
Posted in Banks, European Union, Financial, Healthcare, Infrastructure & Utilities, Investment, Italy, Luxembourg, News, Small Business
Tagged ADCs, Adcytherix, Angelini Industries, Angelini Ventures, antibody-drug conjugates, biotechnology, corporate venture capital, deeptech, digital health, EIB, EIB Partners with Angelini Ventures to Back High-Impact Healthcare Startups and Boost Europe’s Technological Competitiveness, EU competitiveness, European Innovation, European venture capital, Gelsomina Vigliotti, life sciences, medtech, Paolo Di Giorgio, scale-up, Sergio Marullo di Condojanni, startup financing, TechEU, €150 million investment
(IN BRIEF) Researchers from the University of Copenhagen and Rigshospitalet have made significant strides in developing a new treatment for pancreatic cancer using antibody-drug conjugates (ADCs). This targeted therapy promises to improve survival rates by precisely attacking cancer cells while … Read the full press release
Posted in Business, Denmark, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged ADC, antibody-drug conjugates, cancer treatment, chemotherapy, colon cancer, Finsen Laboratory, human clinical trials, immune system, Lars Henning Engelholm, pancreatic cancer, pharmaceutical research, precision medicine, Rigshospitalet, sarcoma, Science Advances, survival rates, targeted therapy, triple-negative breast cancer, University of Copenhagen
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?